AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
44 hedge funds and large institutions have $17.6M invested in AVEO Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
43% less call options, than puts
Call options by funds: $28K | Put options by funds: $49K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
44
Holding in Top 10
1
Calls
$28K
Puts
$49K
Top Buyers
| 1 | +$404K | |
| 2 | +$160K | |
| 3 | +$151K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$121K |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$87K |
Top Sellers
| 1 | -$794K | |
| 2 | -$630K | |
| 3 | -$191K | |
| 4 |
Renaissance Technologies
New York
|
-$146K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$135K |